ShareThis Page
Business

Medical device maker moves headquarters to Greentree

| Wednesday, June 4, 2008

Medical Sensors Technologies Inc., which makes a device to quickly and accurately measure intraocular pressure in the eyes of glaucoma patients, has moved its headquarters from Hanover, Germany, to Greentree.

The company, also known as Mesotec, relocated here to conduct clinical trials with hopes of gaining U.S. Food and Drug Administration approval and launching the product in 2010, said Mesotec in a statement.

The device involves an eye implant, combined with a hand-held device. Mesotec decided to relocate to the Pittsburgh area because of its "quality of life, relatively low cost of doing business... and thriving life sciences community," said CEO Max Ostermeier.

Mesotec will employ a handful of people initially. The company was recruited by the Pittsburgh Regional Alliance during its 2006 and 2008 trips to Europe with the Pittsburgh Symphony Orchestra.

TribLIVE commenting policy

You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.

click me